Abstract
DIABETES TECHNOLOGY SOCIETY
22ND ANNUAL DIABETES TECHNOLOGY MEETING AGENDA
THURSDAY, NOVEMBER 3, 2022
What new developments for measuring glucose are most likely to be widely adopted?
8:00
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Howard Wolpert, MD
Boston Medical Center, Cambridge, Boston, USA
8:05
Isao Shitanda, PhD
Tokyo University of Science, Noda-shi, Chiba, Japan
8:20
Guido Freckmann, MD
Institute for Diabetes Technology Research at Ulm University, Ulm, Germany
8:35
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
8:50
Andreas Pfutzner, MD, PhD
Pfutzner Science and Health Institute, Mainz, Germany
9:05
Jan S. Krouwer, PhD
Krouwer Counseling, Sherborn, Massachusetts, USA
9:20
9:45
What new developments for measuring insulin and ketones are most likely to be widely adopted?
10:10
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
Kirsten N0rgaard, MD, DMSc
Steno Diabetes Center Copenhagen, Herlev, Denmark
10:15
Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
10:30
Jeffrey T. La Belle, PhD
Grand Canyon University, Phoenix, Arizona, USA
10:45
Hazhir Teymourian, PhD
AquilX Inc., San Diego, California, USA
11:00
Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA
11:15
11:40
What are the greatest technical barriers to widespread adoption of virtual diabetes care?
12:40
Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA
Andreas Pfutzner, MD, PhD
Pfutzner Science and Health Institute, Mainz, Germany
12:45
Tejaswi Kompala, MD
Teladoc Health; University of California, San Francisco, San Francisco, California, USA
13:00
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
13:15
Shahid N. Shah, MSc
Netspective Communications LLC, Landover, Maryland, USA
13:30
David N. Kleidermacher, BS
Google, Mountain View, California, USA
13:45
Randi E. Seigel, JD
Manatt, Phelps & Phillips LLP, New York, New York, USA
14:00
14:20
What are the greatest clinical barriers to widespread adoption of virtual diabetes care?
14:45
Andjela Drincic, MD
University of Nebraska Medical Center, Omaha, Nebraska, USA
Rosemary G. Oshinsky, RN, CDE, MSN
New Life New U Holistic Diabetes Care, Bethesda, Maryland, USA
14:50
Erich S. Huang, MD, PhD
Verily Life Sciences, South San Francisco, California, USA; Duke University School of Medicine, Durham, North Carolina, USA
15:05
Pavitra Krishnaswamy, PhD
A*STAR Institute for Infocomm Research, Singapore
15:20
Ateev Mehrotra, MD, MPH
Harvard Medical School, Boston, Massachusetts, USA
15:35
Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA
15:50
Jordan Silberman, MD, PhD
Carelon Digital Platforms (part of Elevance Health), Palo Alto, California, USA
16:05
16:30
FRIDAY, NOVEMBER 4, 2022
8:00
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Jeffrey E. Shuren, MD, JD
Center for Devices and Radiological Health, United States Food and Drug Administration Silverspring, Maryland, USA
8:25
How will CGM data be interpreted in the future?
8:30
Viswanathan Mohan, MD, PhD, DSc
Dr. Mohan’s Diabetes Specialities Centre, Chennai, India; Madras Diabetes Research Foundation, Chennai, India
Jennifer L. Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA
8:35
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
8:50
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
9:05
Michael A. Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA
9:20
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
9:35
9:55
How can the EHR be improved to better accommodate diabetes data?
9:55
Richard M. Bergenstal, MD
International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, USA
Priya Prahalad, MD, PhD
Stanford University, Stanford, California, USA
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
10:00
Christian Selmer, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark
10:15
Juan Espinoza, MD, FAAP
Children’s Hospital Los Angeles, University of Southern California, Los Angeles, California, USA
10:30
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospitals & Clinics, Kansas City, Missouri, USA
10:45
10:55
What are the trends in regulation of diabetes technology?
11:20
Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA
11:25
Yiduo Wu, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA
11:35
Zane Arp, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA
11:45
Bradley M. Thompson, JD, MBA, MADS
Epstein Becker Green PC, Washington, D.C., USA
11:55
Brendan O’Leary, BSME
United States Food and Drug Administration, Silver Spring, Maryland, USA
12:05
12:25
How can digital health tools improve adherence to diabetes treatment?
13:10
William T. Cefalu, MD
NIDDK/NIH, Bethesda, Maryland, USA
Victoria C. Hsiao, MD, PhD
University of California, San Francisco, San Francisco, California, USA
13:15
Felix Lee, MPharm, MSc, MBA
Sanofi, Bridgewater, New Jersey, USA
13:30
Matthew E. Kahn, PhD
University of Southern California, Los Angeles, California, USA
13:45
Elizabeth Holt, MD, FACE
LifeScan Global Corporation, Malvern, Pennsylvania, USA
14:00
Susana R. Patton, PhD
Nemours Children’s Health, Jacksonville, Florida, USA
14:15
14:25
How can technology estimate food intake by persons with diabetes?
14:25
Thanh D. Hoang, DO
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Michelle L. Litchman, PhD, FNP-BC, FAANP, FADCES, FAAN
The University of Utah College of Nursing, Salt Lake City, Utah, USA
14:30
Stavroula G. Mougiakakou, PhD
University of Bern, Bern, Switzerland
14:45
Ricardo Gutierrez-Osuna, PhD
Texas A&M University, College Station, Texas, USA
15:00
Samantha Kleinberg, PhD
Stevens Institute of Technology, Hoboken, New Jersey, USA
15:15
15:25
What are promising trends in controlling automated insulin delivery systems?
15:50
Jeffrey Joseph, DO
The Artificial Pancreas Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Rayhan A. Lal, MD
Stanford University, Stanford, California, USA
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
15:55
Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA
16:05
Marc D. Breton, PhD
University of Virginia, Charlottesville, Virginia, USA
16:15
Jose F. Garcia-Tirado, PhD
University of Virginia, Charlottesville, Virginia, USA
16:25
Frank J. Doyle, PhD
Harvard University, Cambridge, Massachusetts, USA
16:35
Ahmad Haidar, PhD
McGill University, Montreal, Quebec, Canada
16:45
17:00
SATURDAY, NOVEMBER 5, 2022
How can new technology diagnose and prevent hypoglycemia?
8:00
Maya Fayfman, MD
Emory University, Atlanta, Georgia, USA
Brian M. Frier, BSc, MD, FRCP
The University of Edinburgh, Edinburgh, UK
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Maria F. Villa-Tamayo, MSc
University of Virginia, Charlottesville, Virginia, USA
8:20
Michelle F. Magee, MD
Georgetown University, Washington, D.C., USA; MedStar Diabetes Institute, Washington, D.C., USA
8:35
Bastiaan E. de Galan, MD, PhD
Maastricht University Medical Centre, Maastricht, Netherlands; Radboud University Medical Centre, Nijmegen, Netherlands
8:50
Pratik Choudhary, FRCP, MD, MRCP, MBBS
University of Leicester, Leicester, UK
9:05
Sara Bachmann, MD
University Children’s Hospital Basel, Basel, Switzerland
9:20
9:30
How can technology improve insulin delivery?
9:30
Barry H. Ginsberg, MD, PhD
Diabetes Technology Consultants, Arlington, Virginia, USA
Gerold M. Grodsky, PhD
University of California at San Francisco, San Francisco, California, USA
9:35
William C. Roell, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA
9:50
Tim Heise, MD
Profil Institute for Clinical Research, Neuss, Germany
10:05
Eric Renard, MD, PhD, FRCP (Edin)
Lapeyronie Montpellier University Hospital, University of Montpellier, Montpellier, France
10:20
Johan H. Jendle, MD, PhD
Orebro University Hospital, Orebro, Sweden
10:35
10:50
What are promising new types of sensors and measurements of interest for monitoring diabetes?
11:15
Rodolfo J. Galindo, MD, FACE
Emory University, Atlanta, Georgia, USA
Irl B. Hirsch, MD, MACP
University of Washington, Seattle, Washington, USA
11:20
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA
11:30
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
11:40
Christian S. Hansen, MD, PhD
Steno Diabetes Center Copenhagen, Birker0d, Denmark
11:50
Maria Rubega, PhD
University of Padova, Padova, Italy
12:00
12:10
What are important advances in CGM technology contained in commercial products?
12:55
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
13:00
Marc B. Taub, PhD
Abbott Diabetes Care, Alameda, California, USA
13:12
Peter Simpson, MS
Dexcom Inc., San Diego, California, USA
13:24
Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
13:36
Francine R. Kaufman, MD
Senseonics Inc., Germantown, Maryland, USA
13:48
14:10
What types of sensing and treatment technologies can improve outcomes for foot ulcers in diabetes?
14:10
David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:15
David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA
14:25
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:35
Anuradha Godavarty, PhD
Florida International University, Miami, Florida, USA
14:45
14:55
What are some emerging areas of interest in the field of diabetes technology?
15:20
Halis K. Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
Umesh Masharani, MD
University of California, San Francisco, San Francisco, California, USA
15:25
Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia
15:35
Lutz Heinemann, PhD
Science Consulting in Diabetes, Kaarst, Germany
15:45
Erika A. Petersen, MD, FAANS, FACS
University of Arkansas, Little Rock, Arkansas, USA
15:55
16:05
How does a new product with novel technology function?
16:05
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC,FADCES
Weill Cornell Medicine, New York, New York, USA
16:10
Brian Brandell, PhD, MBA
Hemingway Designs LLC, Oregon City, Oregon, USA
Colt Stuart, BSME
Hemingway Designs LLC, Oregon City, Oregon, USA
16:25
16:30